Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date: June 22, 2016
Context: The filing serves as a Regulation FD disclosure to announce the posting of a Corporate Presentation on the company's website and a scheduled corporate update at the JMP Life Sciences Conference in New York City.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate presentation rather than a financial statement.
Material Changes
No material financial changes or operational metrics are detailed in the text of this filing. The primary event is the dissemination of a corporate presentation containing business and product updates.
Guidance, Outlook, and Risks
- Management Commentary: The company provided a Corporate Presentation (Exhibit 99.1) to update stakeholders on current business and products.
- Events: A corporate update was scheduled for the JMP Life Sciences Conference on June 22, 2016, at 9:00 am EDT.
- Legal Status: The information in this Form 8-K and the attached presentation is furnished and not deemed "filed" under Section 18 of the Exchange Act, limiting its incorporation by reference in other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the Corporate Presentation (Exhibit 99.1) attached to this filing for specific business and product updates.
- Confirm the details of the JMP Life Sciences Conference presentation held on June 22, 2016.
- Note that this filing does not contain audited financial data; refer to the company's 10-K or 10-Q filings for financial metrics.